MedTech News
.................... by Andrew Celentano
Bright light suppresses eating and weight gain in mice
Past research has found that exposure to bright lights and high levels of noise can alter both physiological processes and human behavior. For instance, an elevated or limited exposure to bright lights and noise has been found to influence people’s sleeping patterns, circadian rhythm, mood, metabolism, stress levels and mental performance.
CorePlus Collaborates with AIxMED Providing 100% QC on Bladder Cancer Detection with AI
SAN JUAN, Puerto Rico, Jan. 7, 2026 /PRNewswire/ — CorePlus announced the implementation of AIxURO, a state-of-the-art software solution that utilizes artificial intelligence to significantly improve the accuracy and efficiency of bladder cancer detection. This innovative platform enhances traditional urine cytology analysis, providing faster, more precise diagnostics.
AI-generated sensors open new paths for early cancer detection
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
Post-stroke injection protects the brain in preclinical study
Nanomaterial crosses blood-brain barrier, targets harmful inflammation after most common type of stroke
LiverRight Announces Contactless Remote Patient Monitoring Offering
CINCINNATI, Jan. 6, 2026 /PRNewswire/ — LiverRight, the nation’s only National Virtual Clinic for diagnosing and treating Liver Disease in Adults, announces that its telemedicine appointments in 2026 will offer metrics collection using what’s called Contactless Remote Patient Monitoring (RPM).
TYBR Health reports first clinical use of tissue protector in US
The B3 GEL System maintains biomechanical separation throughout the essential healing window.
Biobeat raises $50M to commercialize cuffless blood pressure monitor
The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure monitoring in the U.S.
Stereotaxis MAGiC cardiac ablation catheter wins FDA approval
Stereotaxis (NYSE:STXS) has won FDA approval for its robotically navigated MAGiC ablation catheter, offering a minimally invasive option for patients who otherwise might not be eligible for cardiac ablation to treat complex and critical heart rhythm disorders.